Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease among people who don't drink alcohol, and your risk for developing the condition increases along with your weight.
非酒精性脂肪肝病(NAFLD)是一种常见的慢性肝病，患者大都不喝酒，并且发病的概率与患者的体重成正比。
Patients with nonalcoholic fatty liver disease (NAFLD) have suboptimal levels of cardiovascular fitness, muscle strength, body composition and physical fitness, according to a new study.
根据一项新的研究显示，非酒精性脂肪肝（NAFLD）患者的心血管顺应性，肌力，机体组成和体能都低于最适水平。
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in affluent countries.
在发达国家，非酒精性脂肪性肝病(NAFLD)是一种很常见的慢性肝脏疾病。
Objective to investigate the relationship between metabolic syndrome (MS) and nonalcoholic fatty liver disease (NAFLD) in non-obese impaired glucose tolerant (IGT) subjects.
目的探讨非肥胖的糖耐量受损(igt)者的非酒精性脂肪性肝病(NAFLD)与代谢综合征(MS)的关系。
Objective: To observe the clinical effect and safety of Shugan Jiangzhuo Decoction in treating nonalcoholic fatty liver disease (NAFLD).
目的：观察疏肝降浊汤治疗非酒精性脂肪性肝病的临床疗效及安全性。
Nonalcoholic fatty liver disease(NAFLD) is a kind of chronic liver disease, whose spectrum of the disease includes simple hepar adiposum, steatohepatitis(NASH), hepatic fibrosis, and cirrhosis.
非乙醇性脂肪性肝病（NAFLD）是一种常见的慢性肝病，其疾病谱包括单纯性脂肪肝、非乙醇性脂肪性肝炎（NASH）、肝纤维化及肝硬化。
The prevalence of nonalcoholic fatty liver disease(NAFLD)has been increasing gradually year by year.
非乙醇性脂肪肝（ NAFLD）在临床上的发病率呈逐年上升趋势。
Objective To investigate the effects of "Qianggan Capsule" on hepatic lipid in nonalcoholic fatty liver disease (NAFLD) rats.
目的观察强肝胶囊对非酒精性脂肪肝(NAFLD)大鼠模型肝脏脂质的影响。
The FLD includes alcohol-induced liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD).
临床上分为酒精性肝病（ALD）和非酒精性脂肪性肝病（NAFLD）两大类。
Objective To investigate the effect of rosiglitazone and reduced glutathione on insulin signaling proteins in rats with nonalcoholic fatty liver disease(NAFLD). Methods NAFLD rats were produced.
目的研究罗格列酮联合还原型谷胱甘肽对非酒精性脂肪性肝病（NAFLD）大鼠胰岛素以及胰岛素信号转导相关蛋白表达的影响。
Nonalcoholic fatty liver disease (NAFLD) is a chronic illness with multiple consequences.
非酒精性脂肪性肝病(NAFLD)是一种慢性疾病，多种后果。
Nonalcoholic fatty liver disease (NAFLD) has been consistently found to be associated with features of the metabolic syndrome (MS), a condition carrying a high risk of cardiovascular events.
研究表明，脂肪性肝病使血管壁从解剖学和功能上都发生了较大改变，检测该病对筛查高风险心血管疾病患儿有极为重要的临床意义。
Nonalcoholic fatty liver disease (NAFLD) has been consistently found to be associated with features of the metabolic syndrome (MS), a condition carrying a high risk of cardiovascular events.
研究表明，脂肪性肝病使血管壁从解剖学和功能上都发生了较大改变，检测该病对筛查高风险心血管疾病患儿有极为重要的临床意义。
应用推荐